Drug Origin Transparency Act of 2023
- Last Action
- 6/9/2023
Actions
- 2023-06-09Referred to the Subcommittee on Health.
- 2023-06-05Referred to the House Committee on Energy and Commerce.
- 2023-06-05Introduced in House
- 2023-06-05Introduced in House
CRS Summary
As of 2023-06-05 (00)
Drug Origin Transparency Act of 2023
This bill requires drug manufacturers to report on the suppliers of ingredients used in their products.
Specifically, drug manufacturers must report information relating to the supply chain of their products, including the suppliers of active ingredients and the amount of drugs that are manufactured using those ingredients. Drug manufacturers must also include information about the manufacturers of ingredients on the labels of their products.
Cosponsors (4)
- John Sarbanes (D-MD)
- Angie Craig (D-MN)
- Scott Peters (D-CA)
- Tony Cárdenas (D-CA)
Subjects
- Consumer affairs
- Government information and archives
- Manufacturing
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.